abstract |
The invention relates to the use of the phosphonic analogs of lysine and arginine of the general formula A, wherein R is (4-amino) butane, (3-guanidino) propane, (4-amino) benzyl, (4-guanidino) benzyl, (4-guanidino) ) phenyl, (4-amido) phenyl as protease inhibitors expressed by West Nile Virus (WNV). |